Researchers advance ability to control biological processes at cell-level

November 1, 2012
Tokyo Institute of Technology research: Towards medical treatments using cell level control [research]
Figure 1. Negative feedback regulation of inflammatory responses. The transcription factor NF-κB activates transcription of its target genes, such as A20 and IκBα. Products of these genes function as negative regulators of NF-κB and limit the duration of its activation. This is desirable because persistent activation of NF-κB can lead to various pathogenic conditions such as chronic inflammation, autoimmune diseases, and cancer.

Researchers at Tokyo Institute of Technology and the Weizmann Institute of Science identify a means of controlling biological processes that could help treatments for immune disease, neurological disorders and cancer.

The to a number of signals including inflammatory cytokines, tumor promoters, carcinogens, and chemotherapeutic agents hinge on the transcription factor NF-κB. Rivka Dikstein and colleagues at Tokyo Institute of Technology in Japan and the Weizmann Institute of Science in Israel identify how the protein DSIF controls NF-κB activity. The research may lead to methods for controlling inflammation, and immune responses, as well as the cell cycle processes that can lead to cancer.

Activity of NF-κB is usually transient because some of the gene products function as negative regulators of NF-κB, resulting in a (Figure 1). This is desirable because persistent activation of NF-κB can lead to various pathogenic conditions such as , , and cancer.

Dikstein and colleagues treated cells to reduce the expression of DSIF and monitored the effect on of NF-κB's target genes. They found that in the treated 'DSIF knockdown' cells the levels of these proteins failed to recover following a degradation process. Further investigation revealed that DSIF plays an integral role in the maturation and transport of messenger RNAs (Figure 2).

Tokyo Institute of Technology research: Towards medical treatments using cell level control [research]
Figure 2. The role of DSIF in the control of inflammatory responses. Upon NF-κB activation, DSIF is recruited to the A20 and IκBα genes and contributes to the negative feedback regulation in a unique manner. DSIF facilitates the expression of these genes by stimulating capping, splicing, and export of their mRNAs. Otherwise, these steps are rate-limiting, and A20 and IκBα proteins are not synthesized successfully.

"The unique control of the negative feedback regulator genes by DSIF may be utilized by cells under circumstances in which prolonged NF-κB activity is needed," explain the authors. Their future studies will focus on DSIF under specific settings with a view to identifying for selective manipulation of NF-κB activity.

NF-κB induces responsible for a number of biological processes including inflammation and . Its deregulation is linked to chronic inflammation and cancer but so far the mechanisms behind these processes have not been fully understood.

Nuclear transport is integral to NF-κB activity. In unstimulated cells it is retained inactive in the cytoplasm. Signals that trigger its activation result in its transport into the nucleus where it activates responsive genes, such as A20 and IκBα.

Activity of NF-κB is usually transient because products of these genes function as negative regulators of NF-κB, resulting in a negative feedback and limiting the duration of NF-κB activation (Figure 1). In certain diseases NF-κB activation becomes persistent, perhaps due to an interruption of this feedback loop.

NF-κB activation results in recruitment of the protein DSIF at the target genes A20 and IκBα. The researchers confirmed the role of DSIF in the negative feedback regulation of NF-κB activity by downregulating a protein subunit of DSIF and comparing the treated cells with controls. In untreated cells the levels of proteins for the A20 and IκBα are high. Although the levels diminish significantly in 30 minutes following a process called TNF-α induction, which is caused by degradation of the proteins, within 2 hours the levels recover. In knockdown cells, however, the levels remained diminished 2 hours after TNF-α induction.

Further investigations using chromatin immunoprecipitation assays revealed abnormalities in the synthesis of A20 and IκBα proteins in the knock down cells. A significant portion of the A20 and IκBα mRNAs in the knockdown cells were uncapped and unspliced (Fig. 2).

The researchers also studied how export was affected in DSIF knockdown cells. Export of mature mRNAs from the nucleus to the cytoplasm is a highly regulated process incorporating quality assurance checks. The researchers prepared RNA from cytosolic and nuclear cell fractions for comparison. In knockdown cells following TNF-α induction, the nuclear fractions had much larger amounts of A20 and IκBα than the cytosolic fractions, suggesting accumulation in the nucleus.

The impact observed on the synthesis and export of A20 and IκBα in DSIF knockdown cells was striking. A20 and IκBα are also responsible for regulating other cell signalling processes and it is likely that the effects on associated signalling processes contribute to the overall impact of DSIF knockdown.

As the authors point out, diminished DSIF activity could contribute to pathological states in which NF-κB becomes constitutively active, such as inflammatory and autoimmune diseases, neurological disorders, and cancer. Further work on DSIF activity could help develop new approaches to treating these diseases.

Explore further: Researchers identify novel regulatory mechanism in inflammatory signaling of immune cells

More information: Gil Diamant, Liat Amir-Zilberstein, Yuki Yamaguchi, Hiroshi Handa, and Rivka Dikstein, "DSIF restricts NFκB signaling by coordinating elongation with mRNA processing of negative feedback genes", Cell Reports, 2, (4), pp.722­731, (2012). DOI: 10.1016/j.celrep.2012.08.041.

Related Stories

New book reviews research on key signaling molecule, NF-kB

May 25, 2010

NF-κB is a critical signaling molecule in the immune system that regulates cell survival and cell death, lymphocyte responses, and inflammation. Acting as a transcription factor that can receive several inputs, it coordinates ...

First step to new therapy for chronic bowel disease

July 6, 2010

Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University (UGent) have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. ...

Recommended for you

Study suggests fish can experience 'emotional fever'

November 25, 2015

(—A small team of researchers from the U.K. and Spain has found via lab study that at least one type of fish is capable of experiencing 'emotional fever,' which suggests it may qualify as a sentient being. In their ...

New gene map reveals cancer's Achilles heel

November 25, 2015

Scientists have mapped out the genes that keep our cells alive, creating a long-awaited foothold for understanding how our genome works and which genes are crucial in disease like cancer.

Insect DNA extracted, sequenced from black widow spider web

November 25, 2015

Scientists extracted DNA from spider webs to identify the web's spider architect and the prey that crossed it, according to this proof-of-concept study published November 25, 2015 in the open-access journal PLOS ONE by Charles ...

How cells in the developing ear 'practice' hearing

November 25, 2015

Before the fluid of the middle ear drains and sound waves penetrate for the first time, the inner ear cells of newborn rodents practice for their big debut. Researchers at Johns Hopkins report they have figured out the molecular ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.